Donato Nitti

Q: What Schools Are Affiliated With Donato Nitti

Donato Nitti is affiliated with the following schools: University of Padua, University of Tübingen

Donato Nitti's AcademicInfluence.com Rankings

Donato Nitti

Philosophy

#9948

World Rank

#13580

Historical Rank

Logic

#6899

World Rank

#8457

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Donato Nitti's Degrees

Doctorate Medicine University of Naples Federico II
PhD Biomedical Sciences University of California, San Francisco

Why Is Donato Nitti Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donato Nitti's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. (2008) (543)
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. (2008) (404)
Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. (2010) (393)
Nitric oxide, a double edged sword in cancer biology: Searching for therapeutic opportunities (2007) (383)
The Ratio Between Metastatic and Examined Lymph Nodes (N Ratio) Is an Independent Prognostic Factor in Gastric Cancer Regardless of the Type of Lymphadenectomy: Results From an Italian Multicentric Study in 1853 Patients (2007) (338)
A Randomized Clinical Trial on Sentinel Lymph Node Biopsy Versus Axillary Lymph Node Dissection in Breast Cancer: Results of the Sentinella/GIVOM Trial (2008) (312)
Tumor necrosis factor, cancer and anticancer therapy. (2005) (311)
IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1 (2009) (301)
Bleomycin-Based Electrochemotherapy: Clinical Outcome from a Single Institution’s Experience with 52 Patients (2008) (276)
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. (2004) (252)
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. (2008) (217)
Part I: Vaccines for solid tumours. (2004) (212)
Circulating tumor cells: the 'leukemic phase' of solid cancers. (2006) (210)
The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis (2006) (208)
Ratio Between Metastatic and Examined Lymph Nodes Is an Independent Prognostic Factor After D2 Resection for Gastric Cancer: Analysis of a Large European Monoinstitutional Experience (2003) (198)
Quantitative real-time PCR: a powerful ally in cancer research. (2003) (183)
Interleukin-6 Blood Level Is Associated With Circulating Carcinoembryonic Antigen and Prognosis in Patients With Colorectal Cancer (2000) (182)
Gastrointestinal stromal tumors: From a surgical to a molecular approach (2003) (163)
Local Excision After Preoperative Chemoradiotherapy for Rectal Cancer: Results of a Multicenter Phase II Clinical Trial (2013) (163)
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? (2007) (156)
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis (2013) (149)
Genetic variation and gastric cancer risk: a field synopsis and meta-analysis (2015) (141)
Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Intraoperative Chemotherapy for Peritoneal Carcinomatosis Arising From Colon Adenocarcinoma (2003) (140)
Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. (2012) (134)
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. (2008) (134)
Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. (2006) (133)
Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial. (1998) (132)
The Potential of Restaging in the Prediction of Pathologic Response After Preoperative Chemoradiotherapy for Rectal Cancer (2007) (129)
Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma (1998) (124)
The prognostic value of serum S100B in patients with cutaneous melanoma: A meta‐analysis (2008) (122)
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma (2004) (119)
A Multicentric Western Analysis of Prognostic Factors in Advanced, Node-Negative Gastric Cancer Patients (2010) (118)
Feasibility of Laparoscopic Sleeve Gastrectomy as a Revision Procedure for Prior Laparoscopic Gastric Banding (2006) (114)
EUS for the staging of gastric cancer: a meta-analysis. (2011) (114)
Circulating Cell-Free DNA: A Promising Marker of Pathologic Tumor Response in Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy (2011) (114)
Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers (2010) (111)
The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series. (2008) (110)
Gastrointestinal carcinoid: epidemiological and survival evidence from a large population-based study (n = 25 531). (2013) (110)
Precancerous lesions in the stomach: from biology to clinical patient management. (2013) (109)
TNF and cancer: the two sides of the coin. (2008) (105)
Telomerase and the search for the end of cancer. (2013) (103)
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? (2017) (103)
Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma (2005) (102)
Sleeve gastrectomy as revisional procedure for failed gastric banding or gastroplasty. (2010) (101)
Final results of a phase III clinical trial of adjuvant chemotherapy with the modified fluorouracil, doxorubicin, and mitomycin regimen in resectable gastric cancer. (1995) (101)
IL-10 stimulatory effects on human NK cells explored by gene profile analysis (2004) (99)
Prevention of postsurgical adhesions with an autocrosslinked hyaluronan derivative gel. (2001) (98)
Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis. (2007) (95)
-174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. (2003) (93)
Relationship Between Pathologic T-Stage and Nodal Metastasis After Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer (2005) (88)
Patient-Reported Outcomes After Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Multicenter Prospective Observational Study (2011) (88)
Extent of lymph node dissection for adenocarcinoma of the stomach. (2015) (87)
Serum Proteomic Analysis Identifies a Highly Sensitive and Specific Discriminatory Pattern in Stage 1 Breast Cancer (2007) (87)
Relationship Between Tumor and Plasma Levels of hTERT mRNA in Patients with Colorectal Cancer: Implications for Monitoring of Neoplastic Disease (2008) (83)
Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. (2012) (82)
Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis (2012) (82)
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway (2008) (81)
Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG. (2006) (80)
Patterns of Recurrence after Resection of Colorectal Liver Metastases: Prediction by Models of Outcome Analysis (2001) (79)
Phase II study on neoadjuvant hyperthermic‐antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas (1994) (79)
Adjuvant portal-vein infusion of fluorouracil and heparin in colorectal cancer: a randomised trial (1998) (78)
Diagnostic and prognostic role of cell‐free DNA testing for colorectal cancer patients (2017) (77)
Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer. (2009) (75)
Gene Expression Profile of Primary Gastric Cancer: Towards the Prediction of Lymph Node Status (2007) (73)
Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node (2008) (71)
Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism (2008) (70)
Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. (2011) (70)
Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. (2006) (68)
Cutaneous melanoma in situ: translational evidence from a large population-based study. (2011) (68)
Axillary recurrence after negative sentinel lymph node biopsy without axillary dissection: a study on 479 breast cancer patients. (2005) (67)
Circulating cell-free DNA: a promising marker of regional lymphonode metastasis in breast cancer patients. (2012) (66)
Indexes of Surgical Quality in Gastric Cancer Surgery: Experience of an Italian Network (2008) (66)
Tumor response is predicted by patient genetic profile in rectal cancer patients treated with neo-adjuvant chemo-radiotherapy (2011) (66)
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing (2010) (66)
CTLA-4 blockade and the renaissance of cancer immunotherapy. (2013) (65)
Metachronous hepatic metastases from gastric carcinoma: a multicentric survey. (2009) (65)
Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer (2013) (63)
DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis. (2009) (63)
Early HER2 dysregulation in gastric and oesophageal carcinogenesis (2012) (63)
Follow-Up After Gastrectomy for Cancer: An Appraisal of the Italian Research Group for Gastric Cancer (2014) (62)
Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast (2005) (62)
Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma (2016) (62)
Telomeres, telomerase and colorectal cancer. (2014) (62)
Telomere-Specific Reverse Transcriptase (hTERT) and Cell-free RNA in Plasma as Predictors of Pathologic Tumor Response in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiotherapy (2012) (60)
Association of p53 Gene and Protein Alterations with Metastases in Colorectal Cancer (1995) (60)
Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET). (2013) (60)
Cysteine and serine proteases in gastric cancer (1995) (59)
Gastric Cancer and Synchronous Hepatic Metastases: Is It Possible to Recognize Candidates to R0 Resection? (2015) (59)
A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation (2006) (58)
Systematic review of surgical treatment of subclinical Cushing's syndrome (2015) (57)
Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study. (2013) (56)
Vitamin D receptor polymorphisms and the risk of cutaneous melanoma (2008) (56)
NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells. (2014) (55)
Health-Related Quality of Life Outcomes in Disease-Free Survivors of Mid-Low Rectal Cancer After Curative Surgery (2008) (55)
Early (sentinel lymph node biopsy‐guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases (2010) (55)
Resection Line Involvement After Gastric Cancer Surgery: Clinical Outcome in Nonsurgically Retreated Patients (2008) (55)
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. (2013) (55)
Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival (2009) (54)
Circulating cell-free DNA, SLC5A8 and SLC26A4 hypermethylation, BRAF(V600E): A non-invasive tool panel for early detection of thyroid cancer. (2013) (54)
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression (2014) (54)
Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high‐risk cutaneous melanoma (2004) (53)
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. (2014) (53)
Autophagy and apoptosis-related genes in chronic liver disease and hepatocellular carcinoma (2012) (53)
Role of resection margins in patients treated with breast conservation surgery (2008) (52)
Laparoscopic distal pancreatectomy: up-to-date and literature review. (2012) (51)
Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome (2002) (51)
Giant fibroadenoma of the breast in adolescents: report of 2 cases. (2009) (50)
Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery (2010) (49)
Multiplexed cell signaling analysis of metastatic and nonmetastatic colorectal cancer reveals COX2-EGFR signaling activation as a potential prognostic pathway biomarker. (2009) (49)
Use of quantitative real-time PCR to determine immune cell density and cytokine gene profile in the tumor microenvironment. (2003) (49)
Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. (2012) (48)
miRNAs in colon and rectal cancer: A consensus for their true clinical value. (2010) (47)
Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis (2017) (47)
Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. (2007) (47)
Peptide-based anticancer vaccines: recent advances and future perspectives. (2009) (47)
Colorectal metastases to the liver: Present status of management (1990) (46)
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. (2013) (45)
Outcome of surgical treatment of primary aldosteronism (2015) (44)
Increased levels of cathepsin B and L, urokinase-type plasminogen activator and its inhibitor type-1 as an early event in gastric carcinogenesis. (1996) (43)
Early detection of melanoma: an educational campaign in Padova, Italy (2000) (43)
HER2 status in gastroesophageal cancer: a tissue microarray study of 1040 cases. (2015) (43)
DNA array-based gene profiling: from surgical specimen to the molecular portrait of cancer. (2005) (42)
Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression. (2009) (42)
Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer. (2006) (42)
Cancer vaccine development: on the way to break immune tolerance to malignant cells. (2004) (41)
Epidermal growth factor receptor (EGFR): mutational and protein expression analysis in gastric cancer. (2006) (41)
Extended lymphadenectomy (D2) in patients with early gastric cancer. (2005) (41)
Sentinel node biopsy performance after neoadjuvant chemotherapy in locally advanced breast cancer: A systematic review and meta‐analysis (2016) (41)
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer (2015) (41)
Hemodynamic and Hormonal Stress Responses to Endotracheal Tube and ProSeal Laryngeal Mask AirwayTM for Laparoscopic Gastric Banding (2012) (41)
In-hospital mortality, 30-day readmission, and length of hospital stay after surgery for primary colorectal cancer: A national population-based study. (2017) (41)
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy (2017) (41)
Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis. (2005) (40)
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients (2015) (40)
Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis (1994) (39)
Detection of Circulating CEA-IgM Complexes in Early Stage Colorectal Cancer (2005) (39)
N-Ratio: a Novel Independent Prognostic Factor for Patients with Stage-III Cutaneous Melanoma (2007) (39)
Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. (1997) (39)
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies (2015) (38)
Operative Link for Gastritis Assessment gastritis staging incorporates intestinal metaplasia subtyping. (2011) (38)
Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials. (2016) (38)
An integrative framework identifies alternative splicing events in colorectal cancer development (2014) (37)
Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. (2012) (37)
Clinical impact of false-negative sentinel lymph nodes in breast cancer. (2008) (37)
Dissecting tumor responsiveness to immunotherapy: the experience of peptide-based melanoma vaccines. (2003) (36)
A novel 10B-enriched carboranyl-containing phthalocyanine as a radio- and photo-sensitising agent for boron neutron capture therapy and photodynamic therapy of tumours: in vitro and in vivo studies. (2006) (36)
Hepatic artery ligation with and without portal infusion of 5-FU. A randomized study in patients with unresectable liver metastases from colorectal carcinoma. The E.O.R.T.C. Gastrointestinal Cancer Cooperative Group (G.I. Group). (1991) (34)
Therapeutics targeting tumor immune escape: Towards the development of new generation anticancer vaccines (2008) (34)
Enhanced EGFR Targeting Activity of Plasmonic Nanostructures with Engineered GE11 Peptide (2017) (34)
Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index (2017) (34)
Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy (2011) (34)
The role of MYH gene in genetic predisposition to colorectal cancer: another piece of the puzzle. (2008) (33)
Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. (2015) (33)
Nuclear p53 protein expression in resected hepatic metastases from colorectal cancer: an independent prognostic factor of survival. (1998) (33)
The SIC-GIRCG 2013 Consensus Conference on Gastric Cancer (2014) (33)
Altered plasma levels of decanoic acid in colorectal cancer as a new diagnostic biomarker (2016) (32)
Sentinel Node Status Prediction by Four Statistical Models: Results From a Large Bi-Institutional Series (n = 1132) (2009) (32)
The Impact of Surgery on Survival of Patients With Cutaneous Melanoma: Revisiting the Role of Primary Tumor Excision Margins (2011) (32)
Long-Term Results of Melphalan-Based Isolated Limb Perfusion With or Without Low-Dose TNF for In-Transit Melanoma Metastases (2010) (32)
Laparoscopic Gastric Plication: An Emerging Bariatric Procedure with High Surgical Revision Rate. (2015) (32)
Colorectal metastases to the liver: Present results and future strategies (1991) (32)
Rectal cancer neoadjuvant treatment in elderly patients. (2006) (31)
Hemodynamic and Hormonal Stress Responses to Endotracheal Tube and ProSeal Laryngeal Mask Airway™ for Laparoscopic Gastric Banding (2013) (31)
Colorectal cancer vaccines: principles, results, and perspectives. (2004) (31)
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma (2017) (30)
Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence. (2002) (30)
Molecular oncology in the post-genomic era: the challenge of proteomics. (2004) (30)
A ten markers panel provides a more accurate and complete microsatellite instability analysis in mismatch repair-deficient colorectal tumors. (2010) (30)
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes (2015) (30)
Prognostic value of subclassification of T2 tumours in patients with gastric cancer (2009) (30)
Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype (2007) (29)
Tumour-localizing and -photosensitising properties of meso-tetra(4-nido-carboranylphenyl)porphyrin (H2TCP). (2007) (29)
Number of Metastatic Sentinel Nodes As Predictor of Axillary Involvement in Patients with Breast Cancer (2004) (28)
Validation of the new AJCC TNM staging system for gastric cancer in a large cohort of patients (n = 2,155): focus on the T category. (2011) (28)
Do Perioperative Blood Transfusions Influence Prognosis of Gastric Cancer Patients? Analysis of 927 Patients and Interactions with Splenectomy (2011) (27)
Laparoscopic Gastric Rebanding for Slippage with Pouch Dilation: Results on 29 Consecutive Patients (2008) (27)
Cancer resistance to type II topoisomerase inhibitors. (2012) (27)
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans (2015) (27)
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma. (2004) (27)
Hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from gastric adenocarcinoma. (2003) (26)
High Risk of Rectal Cancer and of Metachronous Colorectal Cancer in Probands of Families Fulfilling the Amsterdam Criteria (2013) (26)
Prediction of rectal lymph node metastasis by pelvic computed tomography measurement. (2009) (26)
A Pilot Characterization of Human Lung NSCLC by Protein Pathway Activation Mapping (2012) (26)
Long-Term Oncologic Results and Complications After Preoperative Chemoradiotherapy for Rectal Cancer: A Single-Institution Experience After a Median Follow-Up of 95 Months (2009) (25)
Predictive response biomarkers in rectal cancer neoadjuvant treatment. (2014) (25)
Multivariate analysis approach to the plasma protein profile of patients with advanced colorectal cancer. (2006) (25)
Absence of the Cell Cycle Inhibitor p27Kip1 Protein Predicts Poor Outcome in Patients With Stage I-III Colorectal Cancer (1999) (25)
Increased and safer detection of nonrecurrent inferior laryngeal nerve after preoperative ultrasonography (2015) (25)
Non-invasive neoplasia of the stomach (2003) (25)
RNA interference: ready to silence cancer? (2005) (24)
Psychological well‐being outcomes in disease‐free survivors of mid‐low rectal cancer following curative surgery (2011) (24)
Increased TIA‐1 gene expression in the tumor microenvironment after locoregional administration of tumor necrosis factor‐α to patients with soft tissue limb sarcoma (2003) (24)
Hypoxia-Related Proteins in Patients With Rectal Cancer Undergoing Neoadjuvant Combined Modality Therapy (2012) (24)
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. (2014) (24)
Validation of the prognostic value of lymph node ratio in patients with cutaneous melanoma: a population-based study of 8,177 cases. (2011) (24)
Survivin and laryngeal carcinoma prognosis: nuclear localization and expression of splice variants (2012) (23)
Lesions indefinite for intraepithelial neoplasia and OLGA staging for gastric atrophy. (2012) (23)
Management of primary sarcomas of the retroperitoneum. (1993) (23)
Does Resection Line Involvement Affect Prognosis in Early Gastric Cancer Patients? An Italian Multicentric Study (2006) (23)
CA 19-9 determination in gastric justice: Role in identifying gastric cancer and high risk patients (1988) (23)
Maximizing the clinical usefulness of a nomogram to select patients candidate to sentinel node biopsy for cutaneous melanoma. (2011) (23)
Tryptophan metabolism along the kynurenine and serotonin pathways reveals substantial differences in colon and rectal cancer (2017) (22)
Colorectal liver metastasis: towards the integration of conventional and molecularly targeted therapeutic approaches. (2005) (21)
Induction of Endothelial Nitric Oxide Synthase Expression by Melanoma Sensitizes Endothelial Cells to Tumor Necrosis Factor-Driven Cytotoxicity (2004) (21)
Adjuvant therapy for colorectal cancer (1987) (21)
Axillary sentinel lymph nodes in breast cancer: a single lymphatic pathway drains the entire mammary gland. (2005) (21)
[Photodynamic therapy in gastroenterology]. (1990) (20)
Carcinoembryonic antigen in gastric juice collected during endoscopy. Value in detecting high‐risk patients and gastric cancer (1983) (20)
Support Vector Machine Learning Model for the Prediction of Sentinel Node Status in Patients With Cutaneous Melanoma (2006) (20)
Resection of pulmonary metastases from colorectal carcinoma. (1997) (20)
Targeted therapy for colorectal cancer: mapping the way. (2005) (20)
Approach to the surgical management of primary aldosteronism. (2015) (19)
Mass spectrometry in the pharmacokinetic studies of anticancer natural products. (2017) (19)
Increased mitochondrial calcium uniporter in adipocytes underlies mitochondrial alterations associated with insulin resistance. (2017) (19)
C Polymorphism of Interleukin 6 Gene Promoter Affects Interleukin 6 Serum Level in Patients with Colorectal Cancer (2003) (19)
Targeted Therapy Database (TTD): A Model to Match Patient's Molecular Profile with Current Knowledge on Cancer Biology (2010) (18)
Stop-flow technique for loco-regional delivery of antiblastic agents: literature review and personal experience. (2002) (18)
Histopathological characteristics of subsequent melanomas in patients with multiple primary melanomas (2014) (18)
Circulating tumor cells in solid cancer: Tumor marker of clinical relevance? (2008) (17)
Towards the development of tumor necrosis factor (TNF) sensitizers: making TNF work against cancer. (2007) (17)
Treatment options for liver metastases from colorectal cancer. (2003) (17)
IL-4 -588C>T polymorphism and IL-4 receptor alpha [Ex5+14A>G; Ex11+828A>G] haplotype concur in selecting H. pylori cagA subtype infections. (2008) (17)
Pulmonary Lymphangioleiomyomatosis: A Case Report in Postmenopausal Woman Treated with Pleurodesis and Progesterone (Medroxyprogesterone Acetate) (1996) (17)
Prognostic factors in resectable gastric cancer: Results of EORTC study no. 40813 on FAM adjuvant chemotherapy (1995) (16)
Proximal colon cancer in patients aged 51–60 years of age should be tested for microsatellites instability. A comment on the Revised Bethesda Guidelines (2008) (16)
TNF&agr;-Based Isolated Perfusion for Limb-Threatening Soft Tissue Sarcomas: State of the Art and Future Trends (2003) (16)
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations (2013) (16)
Serum Ferritin in Pancreatic Disease (1982) (16)
High prevalence of isolated tumour cells in regional lymph nodes from pN0 colorectal cancer (2006) (16)
Usefulness of MALDI-TOF/MS Identification of Low-MW Fragments in Sera for the Differential Diagnosis of Pancreatic Cancer (2013) (16)
TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial (2008) (16)
Significance of pulmonary nodules in patients with colorectal cancer (2012) (16)
Hepatitis C virus infection associated with human hepatocellular carcinoma (1998) (16)
PKH26 Staining Defines Distinct Subsets of Normal Human Colon Epithelial Cells at Different Maturation Stages (2012) (15)
Recent advances in conventional and molecular prognostic factors for gastric carcinoma. (2008) (15)
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression (2016) (15)
Hepatic arterial infusion for unresectable colorectal liver metastases combined or not with systemic chemotherapy. (2009) (15)
Gastric non-Hodgkin's lymphoma: analysis of 252 patients from a multicenter study. (1999) (15)
miR-19a and SOCS-1 expression in the differential diagnosis of laryngeal (glottic) verrucous squamous cell carcinoma (2015) (15)
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal sarcomatosis: long-term outcome from a single institution experience. (2013) (15)
Correlation between Magnetic Resonance Imaging and Histopathological Tumor Response after Neoadjuvant Chemotherapy in Breast Cancer (2008) (15)
Evaluation of Clinical Efficacy of New Medical Treatments in Advanced Colorectal Cancer. Results of a Workshop Organized by the Eortc Gitccg (1998) (14)
Glutathione S-Transferase P1 Ile105Val Polymorphism is Associated with Haematological Toxicity in Elderly Rectal Cancer Patients Receiving Preoperative Chemoradiotherapy (2008) (14)
The effects of acupuncture after thyroid surgery: A randomized, controlled trial. (2014) (14)
Separate cavity margins excision as a complement to conservative breast cancer surgery. (2010) (14)
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy (2015) (14)
Serum seleno-proteins status for colorectal cancer screening explored by data mining techniques - a multidisciplinary pilot study (2012) (14)
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma (2004) (14)
Temporary occlusion of the hepatic artery plus infusion and systemic chemotherapy for inoperable cancer of the liver. (1980) (13)
Celiomesenteric trunk aneurysm. (2009) (13)
Lymphadenectomy in patients with gastric cancer. A critical review. (2003) (13)
Impact of recent legislative bills regarding clinical research on Italian ethics committee activity (2008) (13)
Rectum-Sparing Surgery May be Appropriate for Biallelic MutYH-Associated Polyposis (2010) (13)
Tumoural specimens for forensic purposes: comparison of genetic alterations in frozen and formalin-fixed paraffin-embedded tissues (2011) (13)
Gastric type I carcinoid: a pilot study with human G17DT immunogen vaccination (2011) (12)
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy (2012) (12)
Search of plasma markers for colorectal cancer by matrix-assisted laser desorption/ionization mass spectrometry. (2005) (12)
Soft tissue sarcoma and the hereditary non-polyposis colorectal cancer (HNPCC) syndrome: formulation of an hypothesis (2012) (12)
Effects of A-Line Autoregression Index (AAI) Monitoring on Recovery After Sevoflurane Anesthesia for Bariatric Surgery (2011) (12)
Reducing diagnosis delay in breast cancer possible therapeutic implications. Givio (Interdisciplinary Group for Cancer Care Evaluation). (1986) (11)
Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer (2016) (11)
Adriamycin in hyperthermic perfusion for advanced limb sarcomas. (1992) (11)
Combined evaluation of serum ribonuclease and ferritin: any advantages in pancreatic cancer diagnosis? (1984) (11)
MALDI-MS-NIST library approach for colorectal cancer diagnosis. (2009) (11)
Intraoperative cytology of pancreatic masses. A 10-year experience. (1995) (11)
Primary great saphenous vein leiomyosarcoma: Report of a case (2008) (11)
CA 50 Determination in body fluids: Can we screen patients at risk for gastric cancer? (1991) (11)
Comparison between CT volume measurement and histopathological assessment of response to neoadjuvant therapy in rectal cancer. (2012) (10)
SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer (2017) (10)
5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results. (2006) (10)
Human miRNome profiling in colorectal cancer and liver metastasis development (2014) (10)
Doxorubicin Activity Is Enhanced by Hyperthermia in a Model of Ex Vivo Vascular Perfusion of Human Colon Carcinoma (2003) (9)
Ovarian function after pelvic lymph node irradiation in patients with Hodgkin's disease submitted to oophoropexy during laparotomy. (1980) (9)
NOTCH 3 Signaling Regulates MUSASHI-1 Expression in Metastatic Colorectal Cancer Cells (9)
CEA concentration and cytology in duodenal fluid collected during the Secretin-Pancreozymin test. Attempt at an early diagnosis of pancreatic carcinoma by means of simple procedure. (1980) (9)
p53 gene alterations and protein accumulation in colorectal cancer (1996) (9)
Serum ferritin in pancreatic disease. An accurate test of malignancy? (1982) (9)
CEA and ferritin in chronic pancreatic disease: a comparative evaluation. (1985) (8)
Positive experience of Intraperitoneal Chemotherapy followed by Intravenous Chemotherapy in Heavily Pretreated Patients with Suboptimal Residual Ovarian Cancer and Primary Peritoneal Cancer (2010) (8)
CA 19-9 determination in gastric juice: role in identifying gastric cancer and high risk patients. (1988) (8)
Adjuvant FAM2 in resectable gastric cancer. (1989) (8)
Medium chain fatty acids in intrauterine growth restricted and small for gestational age pregnancies (2017) (8)
Matrix-Assisted Laser Desorption/Ionization, Nanostructure-Assisted Laser Desorption/Ionization and Carbon Nanohorns in the Detection of Antineoplastic Drugs. 1. The Cases of Irinotecan, Sunitinib and 6-Alpha-Hydroxy Paclitaxel (2014) (8)
Colorectal cancer metastatic phenotype stimulates production by fibroblasts of N-terminal peptide of type III collagen: clinical implications for prognosis. (2001) (8)
Cross-validation of a mass spectrometric-based method for the therapeutic drug monitoring of irinotecan: implementation of matrix-assisted laser desorption/ionization mass spectrometry in pharmacokinetic measurements (2016) (8)
Germline polymorphisms of circadian genes and gastric cancer predisposition (2020) (8)
True versus Mild Hyperthermia during Isolated Hepatic Perfusion: Effects on Melphalan Pharmacokinetics and Liver Function (2004) (8)
Correlation Between Melphalan Pharmacokinetics and Hepatic Toxicity Following Hyperthermic Isolated Liver Perfusion for Unresectable Metastatic Disease (2007) (7)
An investigation on the nature of the peptide at m/z 904, overexpressed in plasma of patients with colorectal cancer and familial adenomatous polyposis. (2007) (7)
Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis. (2017) (7)
TNFalpha-based isolated perfusion for limb-threatening soft tissue sarcomas: state of the art and future trends. (2003) (7)
Systemic treatments for metastatic cutaneous melanoma: (Protocol) (2014) (7)
Hyperthermic Isolated Perfusion with Low-Dose TNFα and Doxorubicin in Patients with Locally Advanced Soft Tissue Limb Sarcomas (2004) (7)
APCI1307K Mutations and Forkhead Box Gene (FOXO1A): Another Piece of an Interesting Correlation (2012) (7)
Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment. (2012) (7)
Laparoscopy in the abdominal staging of melanoma. (1989) (6)
Hepatic arterial ligation and portal vein infusion: a clinical trial by the Gastrointestinal Tract Cancer Group of the European Organization for Research and Treatment of Cancer. (1986) (6)
Primary rectal carcinoma in patients with stage IV resectable disease at diagnosis. (2007) (6)
Surgical Unit volume and 30-day reoperation rate following primary resection for colorectal cancer in the Veneto Region (Italy) (2015) (6)
Peptide Patterns as Discriminating Biomarkers in Plasma of Patients With Familial Adenomatous Polyposis. (2016) (6)
Factors Predictive of Nonsentinel Lymph Node Involvement and Clinical Outcome in Melanoma Patients With Metastatic Sentinel Lymph Node (2008) (6)
Genetic variation and gastric cancer risk : a fi eld synopsis and meta-analysis (2015) (6)
Adenosquamous gallbladder carcinoma: Multigene hotspot mutational profiling reveals a monoclonal origin of the two components. (2017) (6)
Metastatic colorectal cancer stimulates collagen synthesis by fibroblasts. (2001) (6)
Adjuvant treatment for gastric cancer. (1991) (6)
Multimodality management of recurrent rectal cancer (2002) (5)
Factors affecting the treatment of multiple colorectal adenomas (2012) (5)
Circulating antibodies in malignant melanoma patients. (1979) (5)
Phase-III clinical trial of adjuvant FAM2 (5-FU, adriamycin and mitomycin C) vs control in resectable gastric cancer: a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. (1988) (5)
Erratum: Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma (British Journal of Cancer (2004) 90 (833-837) doi: 10.1038/sj.bjc.6601543) (2004) (5)
Significance of serum ferritin in patients with gastric and colorectal cancer. (1987) (5)
The development of a matrix-assisted laser desorption/ionization (MALDI)-based analytical method for determination of irinotecan levels in human plasma: preliminary results. (2015) (5)
Randomized phase III studies of adjuvant chemotherapy with FAMTX or FEMTX in resected gastric cancer. Pooled results of studies from the EORTC GI-group and the ICCG (2002) (5)
MINT31 methylation in gastric noninvasive neoplasia: potential role in the secondary prevention of gastric cancer (2012) (5)
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker. (2009) (5)
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer (1998) (4)
Gastric juice CEA levels: importance of age and gastric mucosal damage. (1986) (4)
Long-term follow-up after endoscopic forceps biopsies for early stage duodenal carcinoid: case report and review of endoscopic treatments. (2007) (4)
Hepatic Arterial Infusion (HAI) for Unresectable Liver Metastases (ULM) from Colorectal Carcinoma (1997) (4)
Hepatic arterial infusion (HAI) compared to systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma: A systematic review and meta-analysis of randomized controlled trials (2007) (4)
The Inflammatory Milieu of Tumors: Cytokines and Chemokines that Affect Tumor Growth and Metastasis (2018) (4)
[Malfunctioning of linear staplers as a cause of gastro-gastric fistula in vertical gastroplasty]. (1990) (4)
Genetic heterogeneity of variable number tandem repeats in thymidylate synthase gene in colorectal cancer patients. (2004) (4)
Non-invasive neoplasia of the stomach. (2005) (4)
Recent Trends in Adjuvant Therapy for Gastric Cancer (1992) (3)
TNF and Cancer: Friends and/or Foes? (2012) (3)
Adjuvant therapy for colorectal cancer: the EORTC experience and a review of the literature (1987) (3)
Clinical and molecular detection of inherited colorectal cancers in northeast Italy (2012) (3)
Hypoxic antiblastic stop-flow limb perfusion: clinical outcome and pharmacokinetic findings of a novel treatment for in transit melanoma metastases. (2004) (3)
Occurrence of indoleamine 2,3-dioxygenase in human cutaneous malignant melanoma. (1996) (3)
E2F1 copy number variations in germline and breast cancer: a retrospective study of 222 Italian women (2021) (3)
Hyperthermic isolated liver perfusion for unresectable liver cancers: pilot study. (2004) (3)
p65BTK targeting restores the apoptotic response to chemotherapy of p53-null drug-resistant colon cancer cells (2016) (3)
Hyperthermic Isolated Liver Perfusion for Unresectable Liver Cancers: Pilot Study (2004) (3)
Direct involvement of human gastric mucosa in the activation of alimentary pro-carcinogens. (1991) (3)
Patient outcome after complete surgery for retroperitoneal sarcoma. (2013) (3)
Celiomesenteric Trunk Aneurysm: A Case Report (2009) (3)
Alcohol metabolism in the upper digestive tract: its implications with respect to carcinogenesis (1992) (3)
CEA concentration and cytology in duodenal fluid collected during the secretin-pancreozimin test. (1980) (3)
Benign liver tumors in adults: Diagnosis and management (1996) (2)
Hypoxic Antiblastic Stop-Flow Perfusion: Clinical Outcome and Pharmacokinetic Findings (2004) (2)
[Adjuvant chemotherapy after radical liver resection in the treatment of metastases from colorectal carcinoma]. (2009) (2)
Cell-free circulating DNA as a promising marker of colorectal cancer detection and progression. (2016) (2)
Hepatic arterial ligation with and without portal infusion in metastatic colorectal cancer. (1988) (2)
Chestnut ink disease in the Mugello area: damage and control. (2003) (2)
Regional intra-vascular and intra-lymphatic therapy of neoplastic diseases: a review. (1986) (2)
[Controllable gastric banding as an alternative to vertical gastroplasty in the treatment of obesity]. (1991) (2)
IL-6 blood level is associated with circulating CEA and prognosis in patients with colorectal cancer (1999) (2)
The role of circulating cytokines in colorectal carcinoma (2000) (2)
Melanoma with regional lymph nodes metastases: prognostic variables related to survival (1993) (2)
Gastric non-Hodgkin's lymphomas: analysis of 252 patients. A multicenter study. (1999) (1)
126 POSTER The ratio between metastatic and examined lymph nodes (N-ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1,853 patients (2006) (1)
Relationship between pathological T stage and nodal metastases following preoperative chemoradiotherapy for locally advanced rectal cancer (2004) (1)
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group. (1998) (1)
L12Association with programmed death ligand-1 (PDL-1) expression and Helicobacter Pylori infection in patients with non-diffuse type gastric carcinoma (2015) (1)
25 ORAL A randomized clinical trial on sentinel node biopsy versus axillary lymph node dissection in breast cancer: early results of the Sentinella/GIVOM trial (2006) (1)
Coffee consumption and pancreatic cancer: a cancer -controlled case-control study. (1994) (1)
Plasma levels of total RNA and hTERT mRNA as biomarkers of response in rectal cancer patients receiving preoperative chemoradiotherapy. (2010) (1)
Induction of endothelial nitric oxide synthase expression by melanoma cells sensitizes tumor endothelium to TNF-driven apoptosis. (2004) (1)
Hepatic arterial infusion for unresectable liver metastases from colorectal carcinoma. (1997) (1)
[Adjuvant treatment in rectal cancer]. (1992) (1)
D2 or non D2-lymphadenectomy in gastric cancer (2004) (1)
Discriminant analysis in the clinical and biochemical diagnosis of pancreatic cancer and chronic pancreatitis (1985) (1)
Adjuvant Chemotherapy for Gastric Cancer (1994) (1)
Phase III clinical trial of adjuvant FAM2 vs control in resectable gastric cancer: a study of the EORTC gastrointestinal tract cancer cooperative group. (1988) (1)
Tumor immunology. (2007) (1)
L-Tryptophan Metabolism along the Kynurenine Pathway in Human Malignant Melanoma (1984) (1)
7 ORAL Incidence of hereditary colorectal cancer and microsatellite instability in the Padova area (Italy) (2006) (0)
[Retrocaval ureter. Surgical correction by section of the inferior vena cava]. (1977) (0)
SQUAMOUS CELL CARCINOMA ANTIGEN VARIANTS OVEREXPRESSION IN HEPATOCELLULAR CARCINOMA. (2004) (0)
Tumor and Stem Cell Biology NOTCH 3 Signaling Regulates MUSASHI-1 Expression in Metastatic Colorectal Cancer Cells (2014) (0)
Lymph node metastatic fingerprint revealed by genome-wide transcriptional profiling of primary breast cancer (2006) (0)
Relationship between tumor and plasma levels of telomerase reverse transcriptase mRNA in patients with colorectal cancer: implications for non-invasive monitoring of neoplastic disease (2008) (0)
Human gastric-mucosa can activate 2-amino-fluorene (2AF) and nitrosopyrrolidine (NPY), environmental and dietary carcinogens. (1988) (0)
Is extended lymphadenectomy (D2) justified in patients with early gastric cancer (2004) (0)
124. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal sarcomatosis – A single institution experience (2012) (0)
[Peptic ulcer: proposal of a data collection chart for electronic processing]. (1982) (0)
p53gene alterations andprotein accumulation incolorectal cancer (1996) (0)
-174 c>g polymorphism in interleukin-6 gene promoter affects preoperative interleukin-6 serum level in patients with colorectal cancer (2003) (0)
383. Can RECIST be considered a predictor of outcome in patients with liver metastases from colorectal cancer (2014) (0)
375. The role of surgery in the treatment of colorectal liver metastases: What changed over the years? (2014) (0)
[Exploratory laparotomy for Hodgkin's disease in childhood. Presentation of 30 cases]. (1978) (0)
Peptide patterns as discriminating biomarkers in plasma FAP patients (2015) (0)
The role of sentinel node biopsy in breast cancer patients treated with neoadjuvant chemotherapy (2015) (0)
[Current value of diagnostic laparatomy with splenectomy in Hodgkin's disease (critical evaluation of 188 cases)]. (1978) (0)
795 Protein Pathway Activation Mapping of KRAS Mutated NSCLC Clinical Samples Reveals Systemic Pathway Alterations and Point to New Therapeutic Targets for EGFR Resistant Tumors (2012) (0)
THE CagL Glu59 POLYMORPHISM OF H. pylori IS ASSOCIATED WITH AN INCREASED RISK OF GASTRIC CANCER. PRELIMINARY RESULTS FROM AN ITALIAN MULTICENTER STUDY (2014) (0)
Serumproteomic analysis identifiers a Highly sensitive and specific discriminatory pattern in stage I breast cancer (2006) (0)
P.08.4: Prevention of Esophageal Adenocarcinoma in Barrett’s Esophagus Patients: A Moderate Calorie-Protein Restriction Program (CARE-PRO) (2017) (0)
Hyperthermic Isolated Perfusion with Low-Dose TNFα and Doxorubicin in Patients with Locally Advanced Soft Tissue Limb Sarcomas. (2004) (0)
Next-generation sequencing for genetic testing of familial colorectal cancer syndromes (2015) (0)
Hypoxic antiblastic stop-flow limb perfusion: a novel treatment for in transit melanoma metastases. Clinical outcome and pharmacokinetic findings (2004) (0)
6034 POSTER Hypoxie Antiblastic Stop-flow Pelvic Perfusion – a Step in the Therapeutic Flow-chart of Recurrent Colorectal Cancer (2011) (0)
OC.06.4 INSULIN SIGNALING IN BARRETT'S ESOPHAGUS: IN VITRO AND IN PATIENTS STUDIES (2013) (0)
Somatic mutations in APC gene are molecular prognosticators in patients with colorectal carcinoma (2001) (0)
Gene expression profiling of primary and metastatic colorectal cancer (2004) (0)
Plasma Protein Expression Profile In Familial Adenomatous Polyposis And Hereditary Non- Polyposis Colorectal Cancer Syndromes (2005) (0)
Hypoxic antiblastic stop-flow perfusion: clinical outcome and pharmacokinetic findings. (2004) (0)
Subject Index, Vol. 25, 1982 (1982) (0)
383 POSTER Long-term results of preoperative chemoradiation therapy for mid-low locally advanced rectal cancer: a single Institution series (2006) (0)
Treatment of Resectable Advanced Gastric Cancer (2012) (0)
Protein pathway activation mapping of colorectal metastatic progression reveals metastasis-specific network alterations (2012) (0)
Therapeutical options in patients with colorectal liver metastases: state of the art (1994) (0)
26 ORAL Morbidity comparison of sentinel lymph node procedure versus conventional axillary lymph node dissection for breast cancer patients: results of Sentinella - GIVOM, an Italian randomized clinical trial (2006) (0)
Laparoscopic distal pancreatectomy: Up-to-date and literature review PANCREATIC SURGERY AND (2012) (0)
Fistola aorto-digestiva secondaria ad applicazione di protesi aortica. (1973) (0)
45 ORAL “N-ratio” as a novel prognostic factor for patients with stage III cutaneous melanoma (2006) (0)
Genetic Heterogeneity of Variable Number Tandem Repeats in Thymidylate Synthase Gene in Colorectal Cancer Patients (2004) (0)
[Anastomosis between the thoracic duct and esophagus in the treatment of experimental cholestasis]. (1975) (0)
Surgical treatment of metastatic carcinoma of the kidney. (1974) (0)
Hepatic arterial ligation and portal vein infusion. An EORTC Gastrointestinal Tract Cancer Group Clinical Trial. (1986) (0)
Complete and lasting healing of bone melanoma metastasis after hyperthermic limb perfusion. (2009) (0)
Isolated Tumor Cells (ITC) in Regional Lymph Nodes Predict Colorectal Cancer (CRC) Relapse (2011) (0)
We present the experience on 158 patients with a positive resection line collected from 6 italian surgical centres (2005) (0)
P72 FOXO1A and plasma low molecular weight proteins determination: a promising diagnostic approach and biomarker for colorectal tumors (2007) (0)
Use of a prognostic pathway signature for colorectal cancer comprised of EGFR/COX2 and imatinib drug target activation to predict occult metastasis in M0 CRC. (2009) (0)
Metastatic colorectal cancer (mCRC) treatment: A high-volume, single-center, real-life experience. (2016) (0)
comparative cellular signal patway analysis of metastatic colorectal cancer in human and preclinical animal model (2008) (0)
[Complementary treatment to surgery of gastric carcinoma: role of adjuvant and neoadjuvant chemotherapy]. (1997) (0)
Colonic J-pouch reconstruction versus straight colorectal anastomosis after low anterior resection for rectal cancer: impact on anastomotic leak, bowel function and quality of life. A multicentre prospective randomised trial (2010) (0)
Adjuvant chemotherapy and chemoimmunotherapy for gastric carcinoma (1989) (0)
Gastric mucosa may activate 2-amino-fluorene (2AF) and nitrosopyrrolidine (NPY) in humans. (1988) (0)
T-45 Improved diagnostic accuracy for HCC using a combination of IgM-linked biomarkers (2011) (0)
Tumori dei tessuti molli (2009) (0)
Neoadjuvant treatment for rectal cancer in fit and vulnerable patients older than 70 years. (2006) (0)
Patient-reported outcomes following preoperative chemoradiotherapy for rectal cancer: A prospective multicenter observational study (2008) (0)
Standard surgery and adjuvant therapy for colorectal cancer (1999) (0)
Search of plasma markers for colorectal cancer by Maldi mass spectrometry (2004) (0)
Ink disease in Mugello area (Florence). Damages and a control approach [Castanea sativa Mill. - Tuscany] (2003) (0)
Significance of different classes of p53 gene mutation in patients with colorectal cancer (2001) (0)
Pulmonary metastases radiologic imaging and pathologic correlation (1996) (0)
[Vertical gastroplasty. Evaluation of efficacy]. (1990) (0)
P47: Pregnancy outcomes after laparoscopic adjustable gastric banding for morbid obesity (2006) (0)
Medium chain fatty acids in intrauterine growth restricted and small for gestational age pregnancies (2017) (0)
OC.10.3 LONG-TERM PROGNOSTIC IMPACT OF ISOLATED TUMOUR CELLS IN PN0 COLORECTAL CANCER: A PROSPECTIVE MONOINSTITUTIONAL STUDY (2010) (0)
Variables which may have an impact in the decision of the best treatment for patients with attenuated polyposis coli (A-FAP). (2009) (0)
MATRIX METALLOPROTEINASE 9 (MMP9)-IgM COMPLEX: AN EMERGING NOVEL BIOMARKER IN COLORECTAL CANCER (2008) (0)
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis (2013) (0)
MALDI-TOF/MS Biomarkers Discovery for Pancreatic Cancer Diagnosis: Emerging Role of Apolipoprotein A1 and Complement C3 (2012) (0)
Investigations on the spread of ink disease in Mugello area (Florence, Italy): first results. (2000) (0)
The Value and Present Indications of Staging Laparotomy in Hodgkin's Disease (1978) (0)
2203 Association with programmed death ligand-1 (PDL-1) expression and Helicobacter pylori infection in patients with “non diffusive type” gastric carcinoma radically resected (2015) (0)
Identification of patients who most benefit from hepatic arterial infusion (HAI) combined or not with systemic chemotherapy for the treatment of unresectable colorectal liver metastases (2007) (0)
Multimodal Treatment for Peritoneal Carcinomatosis of Digestive Origin (2002) (0)
[Mediastinoscopy: critical evaluation of 150 cases]. (1972) (0)
Outcomes of Adrenalectomy in adrenal incidentalomas with subclinical Cushing's syndrome. (2012) (0)
Efficacy of pTACE (DEBIRI) as a neoadjuvant therapy for colorectal liver metastases (2015) (0)
Personalized therapy for metastatic colorectal cancer: A closer possibility? (2007) (0)
Treatment of a consecutive series of patients with attenuated polyposis coli (AFAP) (2010) (0)
Contents, Vol. 25, 1982 (2004) (0)
Increased TIA-1 gene expression in the tumor microenvironment after locoregional administration of TNF to patients with limb soft tissue sarcoma. (2003) (0)
E2F1 copy number variations in germline and breast cancer: a retrospective study of 222 Italian women (2021) (0)
Retrocaval ureter. Surgical treatment with inferior vena cava transection (1977) (0)
Corrigendum to “Axillary sentinel lymph nodes in breast cancer:a single lymphatic pathway drains the entire mammary gland”[European Journal of Surgical Oncology 31 (2005) 479–484] (2005) (0)
Abstract 3219: Isolated tumor cells (ITC) in regional lymph nodes predict colorectal cancer (CRC) relapse (2011) (0)
352. Gene and MicroRNA Expression Predictive of Tumour Response in Patients Treated with Preoperative Chemoradiotherapy for Rectal Cancer (2012) (0)
Multivariate Analysis Approach to the Serum Peptide Profile of Morbidly Obese Patients (2013) (0)
V75Q576 IL-4Ra variant and IL-4 -588T allele favor cagA-positive Helicobacter pylori infections. (2006) (0)
Lymph node ratio is a powerful prognostic factor in patients receiving preoperative chemoradiotherapy for rectal cancer. (2009) (0)
1 NOTCH 3 SIGNALING REGULATES MUSASHI-1 EXPRESSION IN METASTATIC COLORECTAL CANCER CELLS (2014) (0)
Abstract LB-214: Identification of patients with adenomas or early- and late-stage colon carcinomas using nanoporous silica chips for protein profiling (2010) (0)
Positive experience of Intraperitoneal Chemotherapy followed by Intravenous Chemotherapy in Heavily Pretreated Patients with Suboptimal Residual Ovarian Cancer and Primary Peritoneal Cancer (2010) (0)
Alterations in molecular networks of metastatic colorectal carcinoma reveal organ-specific signatures: Implications for targeted therapy of metastatic disease. (2006) (0)
Phosphoproteomic analysis of metastatic colorectal cancer: A new horizon in targeted therapy development (2006) (0)
Preoperative Chemoradiation and Local Excision for Selected T2-T3 Rectal Cancer Patients (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Donato Nitti?

Donato Nitti is affiliated with the following schools: